10% Off
Glyriva50 mcg
Beximco Pharmaceuticals Ltd.
৳180.00
Add to cart
Generic medicine
Glycopyrronium Bromide: Brands, Price & Uses in Bangladesh
Glycopyrronium Bromide is a synthetic anticholinergic (antimuscarinic) agent used in several distinct clinical settings depending on its formulation.
About Glycopyrronium Bromide
Indications of Glycopyrronium Bromide
Glycopyrronium Bromide is a synthetic anticholinergic (antimuscarinic) agent used in several distinct clinical settings depending on its formulation.
Established/FDA-approved uses
- Injectable form: Given before anesthesia to reduce salivary, tracheobronchial, and pharyngeal secretions and to reduce the risk of aspiration (antisialogogue); given during surgery to block cardiac vagal reflexes (e.g., preventing bradycardia caused by vagal stimulation or certain anesthetic agents); given intravenously together with neostigmine or another anticholinesterase to counteract the muscarinic side effects (bradycardia, excessive secretions) that occur when reversing non-depolarizing neuromuscular blockade at the end of surgery.
- Oral form: Approved for chronic, severe drooling (sialorrhea) associated with neurologic conditions (e.g., cerebral palsy) in children 3 years and older.
- Inhaled form (as glycopyrrolate/glycopyrronium inhalation powder): Long-term, once- or twice-daily maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is a maintenance bronchodilator and is not indicated for relief of acute bronchospasm.
Adjunctive/older uses
- Historically used orally as adjunctive therapy (with other measures) for peptic ulcer disease, to reduce gastric acid secretion; this use has largely been superseded by newer acid-suppressing agents.
The exact indication and approved use depend on the specific formulation (injection, oral, or inhaled) — see Dosage and Administration for formulation-specific details.
Dosage & Administration of Glycopyrronium Bromide
Dosing of Glycopyrronium Bromide depends on the formulation and the indication being treated. The following is general guidance; always follow the specific product labeling and the prescribing physician's instructions.
Injectable Glycopyrronium Bromide (IV/IM)
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Preoperative antisialogogue/antisecretory | 0.004 mg/kg (4 mcg/kg) IM, 30–60 minutes before anesthesia induction | Similar weight-based dosing (4 mcg/kg IM), as directed by the anesthesiologist |
| Intraoperative (to counteract vagal reflexes/bradycardia) | 0.1 mg IV, repeated at 2–3 minute intervals as needed | Weight-based dosing as directed by the anesthesiologist; not established for routine use in neonates |
| Reversal of neuromuscular blockade (with neostigmine) | 0.2 mg Glycopyrronium Bromide for each 1 mg neostigmine, given IV simultaneously | As directed by the anesthesiologist |
Oral Glycopyrronium Bromide
| Indication | Dose |
|---|---|
| Chronic sialorrhea (children 3 years and older with neurologic conditions) | Started at a low weight-based dose given three times daily and titrated gradually upward by the physician to the lowest effective dose, based on response and tolerability, up to a maximum recommended dose set by the prescriber |
| Adjunct in peptic ulcer disease (adults, historical use) | Typically 1–2 mg two to three times daily, as directed by the physician |
Inhaled Glycopyrronium Bromide
One inhalation capsule (delivering the labeled dose) via the specific dry-powder inhaler device, once or twice daily depending on the product, for long-term maintenance of COPD. It is not for use with a spacer, and capsules must not be swallowed.
Renal/Hepatic Adjustment
Glycopyrronium Bromide is eliminated largely by the kidneys; caution and possible dose reduction or an extended dosing interval are recommended in patients with significant renal impairment, particularly with the injectable and oral forms. Formal hepatic dose-adjustment guidance is not well established; use with caution in hepatic impairment.
Side Effects of Glycopyrronium Bromide
Adverse effects of Glycopyrronium Bromide are mainly related to its anticholinergic action and are generally dose-related.
Common
- Dry mouth
- Constipation
- Blurred vision, mydriasis (pupil dilation), photophobia
- Urinary hesitancy or retention
- Decreased sweating
- Tachycardia, palpitations
- Headache, dizziness, drowsiness (especially with inhaled/oral forms)
Less common/serious
- Heat prostration (fever, heat stroke) due to reduced sweating, particularly in hot environments
- Nervousness, insomnia, or confusion (more likely in elderly patients)
- Allergic reactions, including skin rash
- Paradoxical bronchospasm (rare, with inhaled form) — discontinue and seek medical attention if this occurs
- Cardiac arrhythmias in susceptible patients
Contraindications of Glycopyrronium Bromide
Glycopyrronium Bromide is contraindicated in patients with:
- Known hypersensitivity to Glycopyrronium Bromide or any component of the formulation.
- Narrow-angle (angle-closure) glaucoma.
- Obstructive uropathy (e.g., bladder-neck obstruction due to prostatic hypertrophy).
- Obstructive disease of the gastrointestinal tract (e.g., pyloroduodenal stenosis).
- Paralytic ileus or intestinal atony, particularly in the elderly or debilitated patient.
- Toxic megacolon complicating ulcerative colitis.
- Unstable cardiovascular status in acute hemorrhage.
- Myasthenia gravis, except when used specifically to control muscarinic side effects of concurrent anticholinesterase therapy.
Frequently Asked Questions about Glycopyrronium Bromide
What is Glycopyrronium Bromide used for?
Glycopyrronium Bromide is used, depending on its formulation, to reduce secretions and prevent slow heart rate during anesthesia (injection), to treat chronic drooling in children with certain neurologic conditions (oral), and as a long-term maintenance treatment for COPD (inhaled). It is not a single all-purpose medicine — the specific use depends on the form prescribed by your physician.
Can Glycopyrronium Bromide be used to treat acute wheezing or an asthma attack?
No. Inhaled Glycopyrronium Bromide is a long-acting maintenance bronchodilator for COPD and is not effective for rapid relief of an acute asthma or COPD flare-up. A fast-acting rescue inhaler prescribed by your physician should be used for sudden breathing difficulty.
Who should not take Glycopyrronium Bromide?
People with narrow-angle glaucoma, bladder-outlet or urinary obstruction, certain gastrointestinal obstructive conditions, paralytic ileus, toxic megacolon, or known hypersensitivity to Glycopyrronium Bromide should not use it. It also should generally be avoided in myasthenia gravis, except when specifically used to counteract side effects of anticholinesterase treatment. Always inform your physician of your full medical history before starting Glycopyrronium Bromide.
What are the common side effects of Glycopyrronium Bromide?
The most common side effects of Glycopyrronium Bromide are dry mouth, constipation, blurred vision, urinary hesitancy, decreased sweating, and a faster heart rate. Reduced sweating can increase the risk of overheating in hot weather, so caution is advised in warm environments.
Is Glycopyrronium Bromide safe during pregnancy or breastfeeding?
Data on Glycopyrronium Bromide use in pregnancy are limited, so it should be used during pregnancy only if clearly needed and the potential benefit outweighs any possible risk to the fetus, under a physician's guidance. It is not well established whether Glycopyrronium Bromide passes into breast milk, so it should be used cautiously while breastfeeding, and only after consulting a physician.
What should I do if I suspect an overdose of Glycopyrronium Bromide?
An overdose of Glycopyrronium Bromide can cause severe dry mouth, flushing, a very fast heartbeat, agitation, difficulty swallowing, or, in serious cases, breathing difficulty. This is a medical emergency — seek immediate medical attention or contact emergency services/poison control right away rather than trying to manage it at home.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.